Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect on pharmacokinetics of ASTX029 in healthy volunteers
NCT04466514Phase 1Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of beroterkib in solid tumor (3 arms), sponsored by Astex Pharmaceuticals. Primary endpoints: Maximum Plasma Concentration, Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration and 1 more. Started Jul 2020; status: completed.
02
Drugs
beroterkib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04466514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04466514.